Phase 4 Peripheral Neuropathy Trial, Recruiting NCT07558863 Sponsor: The First Affiliated Hospital with Nanjing Medical University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Phase 4 Peripheral Neuropathy Trial, Recruiting

NCT07558863
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old
  • You have been diagnosed with type 2 diabetes, confirmed by standard medical guidelines
  • You are willing to sign a consent form agreeing to take part in the study
  • You are overweight or obese, meaning your body mass index (BMI) is 24 or above (BMI is a measure based on your height and weight)

Who may not be able to join:

  • You are under 18 years old
  • You are currently pregnant or breastfeeding
  • You have been diagnosed with pancreatitis (inflammation of the pancreas), either as a recent or long-term condition
  • You have recently experienced a serious diabetes-related emergency, such as diabetic ketoacidosis or a severe high blood sugar crisis (confirm with trial site)
  • You have an irregular heartbeat, or you currently take medicines that affect your heart rate, such as beta-blockers or certain blood pressure medications (confirm with trial site)
  • You have a thyroid condition of any kind
  • You have serious problems with a major organ, such as heart failure, liver failure, or kidney failure
  • You are not willing or able to sign the informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 13115008178

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
30 March 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

heart rate variability(HRV)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov